Test Code ROPAN Ro52 and Ro60 Antibodies, IgG, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into plastic vial
Secondary ID
615248Useful For
Evaluating patients at risk for connective tissue disease with or without interstitial lung disease
Differentiation of antibodies to Ro52 and Ro60 in patients known to be positive for anti-SS-A (Ro) antibodies
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
RO52 | Ro52 Antibody, IgG, S | Yes | Yes |
RO60 | Ro60 Antibody, IgG, S | Yes | Yes |
Method Name
Chemiluminescent Immunoassay
Reporting Name
Ro52 and Ro60 Antibodies, IgG, SSpecimen Type
SerumSpecimen Minimum Volume
0.8 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 21 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | OK |
Clinical Information
The SS-A/Ro is part of the Ro/La heterogeneous antigenic complex which is made up of three unique proteins (52 kDa Ro, 60 kDa Ro and La) and four small RNA particles.(1,2) Unlike antibodies to SS-B/La that are less common, reported separately and mainly associated with a diagnosis of primary Sjogren’s syndrome, antibodies to SS-A/Ro are the most prevalent specificity among many autoimmune diseases such as primary Sjogren’s syndrome (SS), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), idiopathic inflammatory myopathy (IIM), rheumatoid arthritis (RA), and primary biliary cholangitis (PBC).(2-4) In addition, children born to mothers positive for anti-SS-A/Ro antibodies are at increased risk for congenital heart block.(3)
Historically, Ro52 and Ro60 autoantibodies were considered as a uniform autoantibody-system. Therefore, when anti-Ro52 or anti-Ro60 antibody is positive, the result was typically reported as anti-SSA/Ro antibody positive.(4,5) However, recent studies have provided evidence that Ro60 and Ro52 are not part of a stable macromolecular complex and that anti-Ro52 and anti-Ro60 antibodies have different clinical associations with implications for diagnosis, prognosis and patient management.(4-6)
The Ro52 antigen is also known as TRIM21; this protein has E3 ligase activity and functions in the process of ubiquitination.(1-3) The Ro60 antigen is a 60-kDa RNA-binding protein known to have repair functions for misfolded RNA.(1-3)
Individuals positive for anti-SS-A/Ro antibodies may react with either Ro52, Ro60, or both antigens.(4-6) Patients with only anti-Ro52 antibodies display a higher incidence of IIM,SSc, or interstitial lung disease (ILD).(7). Anti-Ro52 antibodies, in conjunction with antisynthetase antibodies such Jo-1 (others include PL-7, PL-12, EJ, and OJ) are also highly associated with ILD in patients with IIM.(7,8) In contrast, isolated anti-Ro60 antibodies are associated with increased risk for SLE and, to a lesser degree, for SS.(8) Positivity for both anti-Ro52 and anti-Ro60 antibodies are most strongly associated with SS; this association is even stronger if anti-SS-B/La antibodies are also detected.(9) The presence of anti-Ro52 and anti-Ro60 antibodies may also be observed in patients with SLE.(10)
Reference Values
Ro52 ANTIBODY, IgG
<20 CU (negative)
≥20 CU (positive)
Reference values apply to all ages
Ro60 ANTIBODY, IgG
<20 CU (negative)
≥20 CU (positive)
Reference values apply to all ages
Interpretation
The presence of antibodies to both SS-A 52 (Ro52) or SSA 60 (Ro60) is highly suggestive of a diagnosis of Sjogren syndrome (SS), with positivity for Ro60 alone more likely to be associated with systemic lupus erythematosus (SLE).
Antibodies to Ro52 may be present in patients with idiopathic inflammatory myopathy (IIM), systemic sclerosis (SSc) or overlap connective tissue disease (CTD). In CTD, antibodies to Ro52 alone, or in association with other specific autoantibodies may be associated with interstitial lung diseases.
Negative results for antibodies to Ro52 and Ro60 does not exclude the possibility of any CTD, including SS, SLE, SSc, and IIM.
Day(s) Performed
Wednesday
Report Available
2 to 8 daysSpecimen Retention Time
14 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86235 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ROPAN | Ro52 and Ro60 Antibodies, IgG, S | 33610-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
RO52 | Ro52 Antibody, IgG, S | 53017-0 |
RO60 | Ro60 Antibody, IgG, S | 53019-6 |